drugset
drugset / Trial / NCT03902067

UC-MSC Transplantation for Left Ventricular Dysfunction After AMI

NCT03902067 ↗

Phase 1 Withdrawn Shanghai Life Science & Technology Shanghai Jiao Tong University Affiliated Sixth People's Hospital · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

A pilot study to evaluate the safety and feasibility of umbilical cord mesenchymal stem cells in the treatment of acute myocardial infarction by catheter transplantation

Timeline

Start
2024-12-01
Primary completion
2025-12-31
Completion
2025-12-31

Outcome

Outcome not reported

Stopped: “budget control”

Drugs

EvaluationDrugModalityDoseRoute
Subject human umbilical cord mesenchymal stem cells Cell therapy 5e+06 cells Other

Indications

acute myocardial infarction left ventricular failure